{"entity":{"type":"insider","cik":"0001773309","url":"/insider/0001773309","json_url":"/insider/0001773309.json","name":"Bandy Barton P.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":13,"n_filings":12,"first":"2021-09-17","last":"2022-08-11","span_basis":"filed_date"},"name_variants":[{"name":"Bandy Barton P.","source":"filing","n_filings":12,"first_seen":"2021-09-17","last_seen":"2022-08-11"}],"transactions":[{"id":6128973,"accession":"0001235802-22-000091","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001235802-22-000091","line_url":"/filing/0001235802-22-000091#line-1","is_derivative":false,"issuer_cik":"0001427570","issuer_name":"ReShape Lifesciences Inc.","issuer_ticker":"RSLS","issuer_name_source":null,"issuer_url":"/issuer/0001427570","owner_cik":"0001773309","owner_name":"Bandy Barton P.","owner_display_name":"Bandy Barton P.","owner_url":"/insider/0001773309","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock, $0.001 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11674.0,"shares_display":"11,674","price_per_share":0.47,"price_display":"0.47","price_state":"stated","total_value":5486.78,"total_display":"5,486.78","total_whole":"5,487","shares_owned_after":773098.0,"shares_owned_after_display":"773,098","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-05","filed_date":"2022-08-11","scope":"insider"},{"id":6113703,"accession":"0001235802-22-000080","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001235802-22-000080","line_url":"/filing/0001235802-22-000080#line-1","is_derivative":false,"issuer_cik":"0001427570","issuer_name":"ReShape Lifesciences Inc.","issuer_ticker":"RSLS","issuer_name_source":null,"issuer_url":"/issuer/0001427570","owner_cik":"0001773309","owner_name":"Bandy Barton P.","owner_display_name":"Bandy Barton P.","owner_url":"/insider/0001773309","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock, $0.001 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11442.0,"shares_display":"11,442","price_per_share":0.55,"price_display":"0.55","price_state":"stated","total_value":6293.1,"total_display":"6,293.10","total_whole":"6,293","shares_owned_after":784772.0,"shares_owned_after_display":"784,772","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-01","filed_date":"2022-07-06","scope":"insider"},{"id":6756199,"accession":"0001235802-22-000078","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001235802-22-000078","line_url":"/filing/0001235802-22-000078","is_derivative":false,"issuer_cik":"0001427570","issuer_name":"ReShape Lifesciences Inc.","issuer_ticker":"RSLS","issuer_name_source":null,"issuer_url":"/issuer/0001427570","owner_cik":"0001773309","owner_name":"Bandy Barton P.","owner_display_name":"Bandy Barton P.","owner_url":"/insider/0001773309","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock, $0.001 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11309.0,"shares_display":"11,309","price_per_share":0.9523865947475462,"price_display":"0.95","price_state":"stated","total_value":10770.54,"total_display":"10,770.54","total_whole":"10,771","shares_owned_after":798913.0,"shares_owned_after_display":"798,913","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-01","filed_date":"2022-06-06","scope":"insider","n_lines":2},{"id":6338244,"accession":"0001235802-22-000059","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001235802-22-000059","line_url":"/filing/0001235802-22-000059#line-1","is_derivative":false,"issuer_cik":"0001427570","issuer_name":"ReShape Lifesciences Inc.","issuer_ticker":"RSLS","issuer_name_source":null,"issuer_url":"/issuer/0001427570","owner_cik":"0001773309","owner_name":"Bandy Barton P.","owner_display_name":"Bandy Barton P.","owner_url":"/insider/0001773309","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock, $0.001 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11417.0,"shares_display":"11,417","price_per_share":0.77,"price_display":"0.77","price_state":"stated","total_value":8791.09,"total_display":"8,791.09","total_whole":"8,791","shares_owned_after":807523.0,"shares_owned_after_display":"807,523","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-05","filed_date":"2022-05-12","scope":"insider"},{"id":6664807,"accession":"0001235802-22-000044","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001235802-22-000044","line_url":"/filing/0001235802-22-000044#line-1","is_derivative":false,"issuer_cik":"0001427570","issuer_name":"ReShape Lifesciences Inc.","issuer_ticker":"RSLS","issuer_name_source":null,"issuer_url":"/issuer/0001427570","owner_cik":"0001773309","owner_name":"Bandy Barton P.","owner_display_name":"Bandy Barton P.","owner_url":"/insider/0001773309","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock, $0.001 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11063.0,"shares_display":"11,063","price_per_share":1.13,"price_display":"1.13","price_state":"stated","total_value":12501.19,"total_display":"12,501.19","total_whole":"12,501","shares_owned_after":818940.0,"shares_owned_after_display":"818,940","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-01","filed_date":"2022-04-08","scope":"insider"},{"id":6756184,"accession":"0001235802-22-000034","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001235802-22-000034","line_url":"/filing/0001235802-22-000034#line-1","is_derivative":false,"issuer_cik":"0001427570","issuer_name":"ReShape Lifesciences Inc.","issuer_ticker":"RSLS","issuer_name_source":null,"issuer_url":"/issuer/0001427570","owner_cik":"0001773309","owner_name":"Bandy Barton P.","owner_display_name":"Bandy Barton P.","owner_url":"/insider/0001773309","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock, $0.001 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6538.0,"shares_display":"6,538","price_per_share":1.06,"price_display":"1.06","price_state":"stated","total_value":6930.28,"total_display":"6,930.28","total_whole":"6,930","shares_owned_after":830003.0,"shares_owned_after_display":"830,003","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-28","filed_date":"2022-03-02","scope":"insider"},{"id":6616998,"accession":"0001235802-22-000022","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001235802-22-000022","line_url":"/filing/0001235802-22-000022#line-1","is_derivative":false,"issuer_cik":"0001427570","issuer_name":"ReShape Lifesciences Inc.","issuer_ticker":"RSLS","issuer_name_source":null,"issuer_url":"/issuer/0001427570","owner_cik":"0001773309","owner_name":"Bandy Barton P.","owner_display_name":"Bandy Barton P.","owner_url":"/insider/0001773309","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock, $0.001 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8324.0,"shares_display":"8,324","price_per_share":1.22,"price_display":"1.22","price_state":"stated","total_value":10155.28,"total_display":"10,155.28","total_whole":"10,155","shares_owned_after":836541.0,"shares_owned_after_display":"836,541","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-31","filed_date":"2022-02-02","scope":"insider"},{"id":6664802,"accession":"0001235802-22-000020","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001235802-22-000020","line_url":"/filing/0001235802-22-000020#line-1","is_derivative":false,"issuer_cik":"0001427570","issuer_name":"ReShape Lifesciences Inc.","issuer_ticker":"RSLS","issuer_name_source":null,"issuer_url":"/issuer/0001427570","owner_cik":"0001773309","owner_name":"Bandy Barton P.","owner_display_name":"Bandy Barton P.","owner_url":"/insider/0001773309","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock, $0.001 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7150.0,"shares_display":"7,150","price_per_share":1.79,"price_display":"1.79","price_state":"stated","total_value":12798.5,"total_display":"12,798.50","total_whole":"12,799","shares_owned_after":844865.0,"shares_owned_after_display":"844,865","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-04","filed_date":"2022-01-28","scope":"insider"},{"id":4498110,"accession":"0001235802-21-000141","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001235802-21-000141","line_url":"/filing/0001235802-21-000141#line-1","is_derivative":false,"issuer_cik":"0001427570","issuer_name":"ReShape Lifesciences Inc.","issuer_ticker":"RSLS","issuer_name_source":null,"issuer_url":"/issuer/0001427570","owner_cik":"0001773309","owner_name":"Bandy Barton P.","owner_display_name":"Bandy Barton P.","owner_url":"/insider/0001773309","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock, $0.001 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13427.0,"shares_display":"13,427","price_per_share":1.83,"price_display":"1.83","price_state":"stated","total_value":24571.41,"total_display":"24,571.41","total_whole":"24,571","shares_owned_after":852015.0,"shares_owned_after_display":"852,015","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-02","filed_date":"2021-12-09","scope":"insider"},{"id":4395280,"accession":"0001235802-21-000131","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001235802-21-000131","line_url":"/filing/0001235802-21-000131#line-1","is_derivative":false,"issuer_cik":"0001427570","issuer_name":"ReShape Lifesciences Inc.","issuer_ticker":"RSLS","issuer_name_source":null,"issuer_url":"/issuer/0001427570","owner_cik":"0001773309","owner_name":"Bandy Barton P.","owner_display_name":"Bandy Barton P.","owner_url":"/insider/0001773309","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock, $0.001 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13505.0,"shares_display":"13,505","price_per_share":2.69,"price_display":"2.69","price_state":"stated","total_value":36328.45,"total_display":"36,328.45","total_whole":"36,328","shares_owned_after":865442.0,"shares_owned_after_display":"865,442","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-02","filed_date":"2021-11-16","scope":"insider"},{"id":4640113,"accession":"0001235802-21-000127","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001235802-21-000127","line_url":"/filing/0001235802-21-000127#line-1","is_derivative":false,"issuer_cik":"0001427570","issuer_name":"ReShape Lifesciences Inc.","issuer_ticker":"RSLS","issuer_name_source":null,"issuer_url":"/issuer/0001427570","owner_cik":"0001773309","owner_name":"Bandy Barton P.","owner_display_name":"Bandy Barton P.","owner_url":"/insider/0001773309","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock, $0.001 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12565.0,"shares_display":"12,565","price_per_share":2.77,"price_display":"2.77","price_state":"stated","total_value":34805.05,"total_display":"34,805.05","total_whole":"34,805","shares_owned_after":878947.0,"shares_owned_after_display":"878,947","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-01","filed_date":"2021-10-12","scope":"insider"},{"id":5233072,"accession":"0001790300-21-000011","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001790300-21-000011","line_url":"/filing/0001790300-21-000011#line-3","is_derivative":false,"issuer_cik":"0001427570","issuer_name":"ReShape Lifesciences Inc.","issuer_ticker":"RSLS","issuer_name_source":null,"issuer_url":"/issuer/0001427570","owner_cik":"0001773309","owner_name":"Bandy Barton P.","owner_display_name":"Bandy Barton P.","owner_url":"/insider/0001773309","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock, $0.001 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":294494.0,"shares_display":"294,494","price_per_share":2.89,"price_display":"2.89","price_state":"stated","total_value":851087.66,"total_display":"851,087.66","total_whole":"851,088","shares_owned_after":891512.0,"shares_owned_after_display":"891,512","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-10","filed_date":"2021-09-17","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":13,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":13,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":13},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001427570","name":"ReShape Lifesciences Inc.","url":"/issuer/0001427570","role":"Director, Officer (President and CEO)","n_filings":12,"first_seen":"2021-09-17","last_seen":"2022-08-11"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001773309","retrieved_at":"2026-08-27T03:50:54+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}